Login

Claire Meaton

ORCID: 0009-0002-2988-5941
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5034700615
Research Areas
  • Multiple Sclerosis Research Studies
  • Peripheral Neuropathies and Disorders
  • Trauma and Emergency Care Studies
  • Emergency and Acute Care Studies
  • Rheumatoid Arthritis Research and Therapies
  • Autoimmune Bullous Skin Diseases
  • Hip and Femur Fractures

Royal Perth Hospital
 2024

The University of Western Australia
 2024

The Royal Melbourne Hospital
 2021

 Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study
OPENALEX - Publications 
Nabil Seery Sifat Sharmin Vivien Li Ai‐Lan Nguyen Claire Meaton and 14 more Roberts Atvars Nicola Taylor Kelsey Tunnell John P. Carey Mark Marriott Katherine Buzzard Izanne Roos Chris Dwyer Josephine Baker Lisa Taylor Kymble Spriggs Trevor J. Kilpatrick Tomáš Kalinčík Mastura Monif

10.1007/s40263-021-00810-3 article EN CNS Drugs 2021-04-13
 009 Predicting infection risk in multiple sclerosis patients treated with ocrelizumab: a retrospective cohort study
OPENALEX - Publications 
Nabil Seery Sifat Sharmin Vivien Li Ai‐Lan Nguyen Claire Meaton and 14 more Roberts Atvars Nicola Taylor Kelsey Tunnell Joh Carey Mark Marriott Katherine Buzzard Izanne Ross Chris Dwyer Josephine Baker Lisa Taylor Kymble Springs Trevor J. Kilpatrick Tomáš Kalinčík Mastura Monif

<h3>Objective</h3> To examine factors determining risk of self-reported infections and antimicrobial use in patients receiving Ocrelizumab for MS. <h3>Methods</h3> Retrospective, observational cohort study conducted Ocrelizumab-treated at the Royal Melbourne Hospital. The association clinical laboratory with infection rate were estimated using univariate multivariable logistic regression models. <h3>Results</h3> 185 included study, 176 reported 89 (46.1%), 47 (25.3%) was identified. In...

10.1136/bmjno-2021-anzan.9 article EN 2021-08-01
Coming Soon ...